ATE308984T1 - Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen - Google Patents

Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen

Info

Publication number
ATE308984T1
ATE308984T1 AT02717031T AT02717031T ATE308984T1 AT E308984 T1 ATE308984 T1 AT E308984T1 AT 02717031 T AT02717031 T AT 02717031T AT 02717031 T AT02717031 T AT 02717031T AT E308984 T1 ATE308984 T1 AT E308984T1
Authority
AT
Austria
Prior art keywords
activation
treatment
ppar
gamma receptor
diseases responsive
Prior art date
Application number
AT02717031T
Other languages
English (en)
Inventor
C. Pisano
T Riccioni
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE308984T1 publication Critical patent/ATE308984T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02717031T 2001-03-16 2002-03-01 Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen ATE308984T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000136A ITRM20010136A1 (it) 2001-03-16 2001-03-16 Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma.
PCT/IT2002/000127 WO2002074291A2 (en) 2001-03-16 2002-03-01 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor

Publications (1)

Publication Number Publication Date
ATE308984T1 true ATE308984T1 (de) 2005-11-15

Family

ID=11455333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02717031T ATE308984T1 (de) 2001-03-16 2002-03-01 Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen

Country Status (20)

Country Link
US (4) US6897235B2 (de)
EP (1) EP1368025B1 (de)
JP (1) JP4276842B2 (de)
KR (1) KR100851678B1 (de)
CN (2) CN1286456C (de)
AT (1) ATE308984T1 (de)
AU (1) AU2002247951B2 (de)
BR (1) BR0208157A (de)
CA (1) CA2440979C (de)
CZ (1) CZ20032523A3 (de)
DE (1) DE60207215T2 (de)
DK (1) DK1368025T3 (de)
ES (1) ES2249568T3 (de)
HK (2) HK1075006A1 (de)
HU (1) HUP0303518A3 (de)
IT (1) ITRM20010136A1 (de)
MX (1) MXPA03008317A (de)
PL (1) PL369295A1 (de)
SK (1) SK12752003A3 (de)
WO (1) WO2002074291A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004022035D1 (de) * 2003-05-14 2009-08-27 Dsm Ip Assets Bv Verwendung von pthalide derivativen zur behandlung
US9308198B2 (en) 2006-09-08 2016-04-12 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced brain disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07285862A (ja) 1994-04-21 1995-10-31 Kokka Iyaku Kanrikyoku Shisen Kokinso Kogyo Kenkyusho 脂質低下剤
JPH107557A (ja) * 1996-06-17 1998-01-13 Banyu Pharmaceut Co Ltd 抗腫瘍性物質スピロラキシン
US6440961B1 (en) * 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
IT1317001B1 (it) * 2000-03-13 2003-05-26 Sigma Tau Ind Farmaceuti Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi.

Also Published As

Publication number Publication date
CN1610545A (zh) 2005-04-27
CA2440979C (en) 2010-07-13
DE60207215D1 (de) 2005-12-15
CA2440979A1 (en) 2002-09-26
JP2004523578A (ja) 2004-08-05
US7276533B2 (en) 2007-10-02
HK1096850A1 (en) 2007-06-15
DK1368025T3 (da) 2005-12-19
US6897235B2 (en) 2005-05-24
CN1839823A (zh) 2006-10-04
US20040092540A1 (en) 2004-05-13
AU2002247951B2 (en) 2007-03-01
MXPA03008317A (es) 2003-12-11
JP4276842B2 (ja) 2009-06-10
EP1368025B1 (de) 2005-11-09
CN100462073C (zh) 2009-02-18
DE60207215T2 (de) 2006-07-20
KR100851678B1 (ko) 2008-08-13
CZ20032523A3 (cs) 2004-05-12
HUP0303518A3 (en) 2005-12-28
US20050131060A1 (en) 2005-06-16
HK1075006A1 (en) 2005-12-02
WO2002074291A3 (en) 2003-03-13
ITRM20010136A1 (it) 2002-09-16
SK12752003A3 (sk) 2004-01-08
KR20040025905A (ko) 2004-03-26
EP1368025A2 (de) 2003-12-10
ITRM20010136A0 (it) 2001-03-16
HUP0303518A2 (hu) 2004-03-01
BR0208157A (pt) 2004-03-02
US20040242675A1 (en) 2004-12-02
WO2002074291A2 (en) 2002-09-26
PL369295A1 (en) 2005-04-18
US20040241228A1 (en) 2004-12-02
ES2249568T3 (es) 2006-04-01
CN1286456C (zh) 2006-11-29

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
BRPI0409109A (pt) novos compostos
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
CU23105A3 (es) DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
GB0222495D0 (en) Compounds
TR200200648T2 (tr) Farmasötik özelliklere sahip yeni dikarboksilik asit türevleri.
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
PT1506185E (pt) Compostos novos e sua utilizacao
BR0314302A (pt) Compostos de pirazol como inibidores do fator de crescimento trnasformante (tgf)
YU82702A (sh) Ortosupstituisani amidi antranilne kiseline i njihova primena kao sredstva za lečenje
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
BR9811093A (pt) Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo)
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
ES2191099T3 (es) Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
ATE308984T1 (de) Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
ES2189213T3 (es) Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2.
BR0113814A (pt) Amidas de ácido fenilciclohexanocarboxìlico e sua aplicação
DK0966455T3 (da) Oxirancarboxylsyrer til behandling af diabetes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368025

Country of ref document: EP

REN Ceased due to non-payment of the annual fee